Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Proctor Hospital
mi
from
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Proctor Hospital
mi
from
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
OSF St. Francis Medical Center
mi
from
Peoria, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Illinois Valley Community Hospital
mi
from
Peru, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Illinois Valley Community Hospital
mi
from
Peru, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Perry Memorial Hospital
mi
from
Princeton, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Perry Memorial Hospital
mi
from
Princeton, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Margaret's Hospital
mi
from
Spring Valley, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Margaret's Hospital
mi
from
Spring Valley, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Carle Cancer Center at Carle Foundation Hospital
mi
from
Urbana, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Carle Cancer Center at Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
McFarland Clinic, PC
mi
from
Ames, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Bettendorf, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Capitol Hospital
mi
from
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Capitol Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Cancer Center at Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Cancer Center at Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Southwest Medical Center
mi
from
Liberal, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Southwest Medical Center
mi
from
Liberal, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Via Christi Cancer Center at Via Christi Regional Medical Center
mi
from
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Via Christi Cancer Center at Via Christi Regional Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Wesley Medical Center
mi
from
Wichita, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Wesley Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Hickman Cancer Center at Bixby Medical Center
mi
from
Adrian, MI
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Hickman Cancer Center at Bixby Medical Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Haematology-Oncology Associates of Ohio and Michigan, PC
mi
from
Lambertville, MI
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Haematology-Oncology Associates of Ohio and Michigan, PC
mi
from
Lambertville, MI
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Community Cancer Center of Monroe
mi
from
Monroe, MI
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Community Cancer Center of Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy Memorial Hospital - Monroe
mi
from
Monroe, MI
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy Memorial Hospital - Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
MeritCare Bemidji
mi
from
Bemidji, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
MeritCare Bemidji
mi
from
Bemidji, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Fairview Ridges Hospital
mi
from
Burnsville, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Fairview Ridges Hospital
mi
from
Burnsville, MN
Click here to add this to my saved trials